Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotonorm in children with short stature secondary to long-term corticoid therapy
NCT00174278Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 1997
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of somatropin, sponsored by Pfizer. Primary endpoints: Height Standard Deviation Score, Standing Height and 5 more. Started Feb 1997; status: completed.
02
Drugs
somatropin
Beyond the preview
Go deeper on NCT00174278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174278.